Connect with us

Health

Cannabinoids reveal promising results in the treatment of Borderline Personality Disorder

Published

em

Photo: DR

One of the investigation carried out by Khiron LifeSciences and coordinated by Guillermo Moreno Sanz suggests that cannabis-based medicines, when used in a controlled clinical environment, can lead to significant improvement in symptoms associated with Borderline Personality Disorder (BPD), also known as Emotionally Unstable Personality Disorder (EUPD). 

The follow-up study used data from the UK patient registry in the program entitled T21 and explored the experiences of seven patients diagnosed with BPD/EUPD who were prescribed cannabis-based medications through Zerenia Clinics located in both the United Kingdom and Colombia.

Most participants were under 30 years of age and had tried several conventional medications. Some had previously used cannabis obtained illegally. In the United Kingdom, patients were prescribed dried cannabis flowers and oral extracts with varying concentrations of CBD and THC, while in Colombia only oils were available on prescription. Participants were initially assessed and followed up one month later.

During the follow-up visit, prescribing psychiatrists rated the patient's improvement on the Clinical Global Impression Improvement (CGI-I) scale and patients were asked to complete the Patient Global Impression Improvement (PGIC) scale.

Six participants reported an improvement in symptoms, with five rating their change as a six on the PGIC scale, indicating a definitive improvement that made a real difference. The authors note that the only patient who did not report any benefit was treated with an oral extract alone, suggesting that rapid administration of inhaled THC or prolonged accumulation of oral CBD at higher doses may be more effective for patients with BPD/EUPD. .

Overall, the treatment was well tolerated and no adverse side effects were reported. The authors concluded that, although the results are limited by the small number of patients involved in the study and the fact that all those who reported benefiting from the use of cannabis flowers were already users with some experience, they believe that cannabinoids present a promising alternative treatment for BPD/EUPD and justify the need for further investigation.

“Cannabinoids may represent a new, effective and safe treatment alternative for patients with EUPD,” said Moreno Sanz. “Our results suggest that, when implemented in a tightly controlled clinical setting, CBMPs can provide substantial improvement in symptoms associated with EUPD, thus justifying the need for further research into this therapeutic strategy.”

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

+ posts
Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

International19 hours ago

USA: Pediatrician Bonni Goldstein launches petition against ban on natural CBD medicines in California

North American pediatrician Bonni Goldstein is warning of the attempt to ban medicines derived from natural CBD in...

International19 hours ago

Europe has almost 23 million users of cannabis, the most consumed of all illicit substances

Cannabis continues to be, by far, the most consumed illicit substance in Europe. These are the conclusions of the “Report...

Events2 days ago

Mary Jane celebrates legal cannabis culture for the first time in Germany

It is next weekend, from the 14th to the 16th of June, that the usual Mary Jane will take place, at the Messe...

Events7 days ago

CB Club brings together cannabis professionals in anticipation of Mary Jane, in Berlin

In anticipation of the CB Expo (Cannabis Business Expo and Conference), which will take place in Dortmund, in September, the CB Company will...

report1 weeks ago

South Africa: the legalization of an already thriving industry

In the weeks leading up to the General Assembly elections in South Africa, last Wednesday, May 29, there were...

Interviews1 weeks ago

Rui Reininho: “I think it's really weird that my GNR colleagues are poking their noses into people's properties to see what this plant does”

Rui Reininho, Portuguese musician who became famous as the lead singer of GNR, needs no introduction. Contrary to what many people think, he did not found...

News2 weeks ago

Canada: Study shows that using cannabis reduces methamphetamine consumption

Polydrug users, individuals who consume several substances, often turn to cannabis as a way to reduce their consumption...

Events4 weeks ago

CannaTrade returns to Zurich from May 24th to 26th

CannaTrade – Zurich International Hemp Fair and Festival comes of age in 2024, celebrating its 18th...

Press Releases4 weeks ago

SOMAÍ Group and its subsidiary RPK Biopharma expand partnership with Cookies to include Europe and the United Kingdom

LISBON, PORTUGAL, May 16, 2024 /EINPresswire.com/ — The SOMAÍ Group (“SOMAÍ”) and its subsidiary, RPK Biopharma expanded...

National4 weeks ago

Portugal: Estimated CBD consumption increases despite ban

The “Cannabis in Portugal” report, carried out by Euromonitor International, released the most recent data on the cannabis industry,...